Competitor Analysis: Anti-Infective Peptides

Date: October 16, 2014
Pages: 68
US$ 446.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C2E9F84351BEN

Download PDF Leaflet

Competitor Analysis: Anti-Infective Peptides
Competitor Analysis: Anti-Infective Peptides

The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Anti-Bacterial Peptides

Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram-positive and gram-negative infections, prevention of catheter-related infections, otitis media, gingivitis and many more.

Anti-Fungal Peptides

Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more.

Anti-Viral Peptides

Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).

The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
2013 Sales of Major Anti-Infective Peptides
Anti-Bacterial Peptides
Anti-Fungal Peptides
Anti-Viral Peptides
Corporate Anti-Infective Peptide R&D Pipelines
Skip to top

Competitor Analysis: Anti-Infective Antibodies US$ 1,086.00 Nov, 2011 · 160 pages
Anti-Infectives: Market Research Report US$ 3,950.00 Feb, 2010 · 825 pages
Anti-Infective Pharmaceuticals Market in India 2012 US$ 1,995.00 Apr, 2012 · 82 pages
Competitor Analysis: Cardiovascular Peptides US$ 383.00 Oct, 2014 · 59 pages

Ask Your Question

Competitor Analysis: Anti-Infective Peptides
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: